Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000390652 | SCV000335169 | benign | not specified | 2015-10-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000633084 | SCV000754296 | benign | Spastic paraplegia | 2023-12-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001561554 | SCV001784180 | likely benign | not provided | 2022-09-16 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Ambry Genetics | RCV002338831 | SCV002619121 | benign | Inborn genetic diseases | 2017-06-30 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002487201 | SCV002802641 | likely benign | Syndromic X-linked intellectual disability Claes-Jensen type | 2021-08-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003967722 | SCV004778897 | benign | KDM5C-related disorder | 2019-09-24 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |